Literature DB >> 11929643

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables.

Jan Endrikat1, C Klipping, M Cronin, C Gerlinger, A Ruebig, W Schmidt, B Düsterberg.   

Abstract

In this open label, randomized study we compared the influence of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol (EE) and 100 microg levonorgestrel (20 EE) with a reference preparation containing 30 microg EE and 150 microg levonorgestrel (30 EE) on hemostatic, lipids, and carbohydrate metabolism variables. Data from 48 volunteers were obtained. The direction of the change (increase or decrease) in most of the hemostatic variables were similar in both treatment groups. In particular, prothrombin fragment 1 + 2 increased during treatment, reaching a median percent change of 40% in the 20 EE group and of 17% in the 30 EE group after one year. D-Dimer fibrin split products remained virtually unchanged, with no change at Cycle 13. The median HDL2 cholesterol levels decreased by 26% in the 20 EE group and by 39.8% in 30 EE group (p = 0.0045 for group difference) after one year. The median one year change for LDL cholesterol was 3.23% in the 20 EE group, compared to 25% in the 30 EE group, for VLDL 11.1% compared to 38.8%, respectively, and for total triglycerides 10.0% compared to 37.5%, respectively. The median absolute change for the area under the curve (AUC)(0-3h) for glucose at treatment Cycle 13 was 41.25 mmol/L x min in the 20 EE group and 73.50 mmol/L x min in the 30 EE group. The AUC(0-3h) insulin at treatment Cycle 13 decreased in the 20 EE group by 1635.0 pmolL x min and increased in the 30 EE group by 11797.5 pmolL x min (p = 0.0491 for group difference). Both study treatments were safe and well tolerated by the volunteers. In conclusion, the balanced one-third dose reduction in this new oral contraceptive evoked similar effects on the hemostatic variables, but favorable results for the lipid and carbohydrate profiles.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929643     DOI: 10.1016/s0010-7824(01)00316-x

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  12 in total

Review 1.  Choosing the best contraceptive method for the adult with congenital heart disease.

Authors:  Candice K Silversides; Mathew Sermer; Samuel C Siu
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

2.  Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study.

Authors:  Sahar M El-Haggar; Tarek M Mostafa
Journal:  Endocrine       Date:  2014-12-25       Impact factor: 3.633

3.  Ovarian Lipid Metabolism Modulates Circulating Lipids in Premenopausal Women.

Authors:  Jeffrey T Jensen; Ilana B Addis; Jon D Hennebold; Randy L Bogan
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

Review 4.  Metabolic effects of contraceptive steroids.

Authors:  Regine Sitruk-Ware; Anita Nath
Journal:  Rev Endocr Metab Disord       Date:  2011-06       Impact factor: 6.514

Review 5.  Contraceptive hormone use and cardiovascular disease.

Authors:  Chrisandra L Shufelt; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

6.  Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study.

Authors:  D Romualdi; S De Cicco; M Busacca; D Gagliano; A Lanzone; M Guido
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

7.  Effects of oral contraceptives on serum concentrations of adipokines and adiposity indices of women with polycystic ovary syndrome: a randomized controlled trial.

Authors:  M Amiri; M Rahmati; M Hedayati; F Nahidi; F Ramezani Tehrani
Journal:  J Endocrinol Invest       Date:  2020-07-17       Impact factor: 4.256

8.  Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism.

Authors:  Ulla M Ågren; Marjatta Anttila; Kristiina Mäenpää-Liukko; Maija-Liisa Rantala; Hilkka Rautiainen; Werner F Sommer; Ellen Mommers
Journal:  Eur J Contracept Reprod Health Care       Date:  2011-12       Impact factor: 1.848

Review 9.  Ethynilestradiol 20 mcg plus Levonorgestrel 100 mcg: Clinical Pharmacology.

Authors:  Stefano Lello; Andrea Cavani
Journal:  Int J Endocrinol       Date:  2014-11-16       Impact factor: 3.257

10.  Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community.

Authors:  George A Asare; Sheila Santa; Robert A Ngala; Bernice Asiedu; Daniel Afriyie; Albert Gb Amoah
Journal:  Int J Womens Health       Date:  2014-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.